IMM — ImmuPharma Cashflow Statement
0.000.00%
Last trade - 00:00- £9.79m
- £9.58m
Annual cashflow statement for ImmuPharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.08 | -6.28 | -5.59 | -6.59 | -3.03 |
| Depreciation | |||||
| Non-Cash Items | 2.17 | 1.46 | 1.43 | 0.619 | 0.115 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.05 | 0.511 | 0.656 | 1.02 | 0.449 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.72 | -4.22 | -3.33 | -4.83 | -2.35 |
| Capital Expenditures | -0.103 | -0.107 | -0.36 | -0.051 | -0.106 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.99 | 0.006 | -0.209 | 0.001 | 0.029 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.09 | -0.101 | -0.569 | -0.05 | -0.077 |
| Financing Cash Flow Items | -0.714 | -2.24 | -0.945 | -2.12 | -0.803 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.15 | 0.326 | 8.37 | 0.702 | 1.55 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.18 | -3.55 | 4.5 | -4.21 | -0.982 |